文献速递多重用药认知障碍与谵妄衰弱、肌少症与跌倒

精神药物与心血管药物医源性警示与阿尔茨海默病患者住院风险的关联

Association Between Psychotropic and Cardiovascular Iatrogenic Alerts and Risk of Hospitalizations in Elderly People Treated for Dementia: A Self-Controlled Case Series Study Based on the Matching of 2 French Health Insurance Databases.
PubMed 文献 · J Am Med Dir Assoc · 2017-03-18

基于法国两大医保数据库匹配的自身对照病例系列研究,纳入10754例≥75岁接受阿尔茨海默病治疗的参保人,分析5项医源性警示与住院的关联。结果显示,存在医源性警示期间住院率增加,估算22%的住院与医源性警示相关,其中80%归因于精神药物类警示。

要点

  • 医源性警示期间住院率每年增加0.36次,无警示期间为0.23次,住院数翻倍。
  • 估算22%的住院与医源性警示相关,其中80%由精神药物类警示所致。
  • 医源性警示可作为评估阿尔茨海默病患者处方适宜性的简易临床工具。

核心结论

  • 医源性警示与接受阿尔茨海默病治疗的老年患者住院风险增加相关,估算22%的住院与医源性警示相关。

研究设计与样本

  • 为期2年(2011年1月1日至2012年12月31日)的法国全国数据库纵向研究,设计类似自身对照病例系列,通过匹配两大法国国家医保数据库获取处方与住院数据。
  • 纳入2011年1月1日存活、年龄≥75岁且接受阿尔茨海默病治疗的全部参保人,共10754例,分析覆盖四个6个月周期。

主要发现

  • 同一患者有医源性警示期间住院率每年增加0.36次,无警示期间为0.23次,住院数翻倍(比例倍数变化=1.9,95%CI 1.8–2.1)。
  • 估算全部住院中22%(95%CI 20%–23%)与医源性警示相关,其中80%归因于精神药物类医源性警示。

关键数值与推荐

  • 医源性警示定义为:半衰期长的苯二氮䓬类药物;阿尔茨海默病患者使用抗精神病药物;同时处方3种及以上精神药物;同时处方2种及以上利尿剂;同时处方4种及以上降压药。

临床怎么用

  • 处方医生可将5项医源性警示作为简易且临床相关的工具,评估阿尔茨海默病老年患者处方的适宜性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Elderly people are at risk of repeated hospitalizations, some of which may be drug related and preventable. In 2011, a group of French healthcare experts selected 5 iatrogenic alerts (IAs), based on criteria identified in a literature search and from their professional experience, to assess the appropriateness of medication in elderly patients. OBJECTIVES: Our objective was to examine the association between hospitalizations and IAs in elderly patients treated for Alzheimer disease who are particularly sensitive to adverse drug events. DESIGN: A 2-year (January 1, 2011, to December 31, 2012) longitudinal national database study, with a study design similar to self-controlled case series, was performed to analyze data on drug prescriptions and hospitalization. IAs were defined as (1) long half-life benzodiazepine; (2) antipsychotic drugs in patients with Alzheimer disease; (3) co-prescription of 3 or more psychotropic drugs; (4) co-prescription of 2 or more diuretics; and (5) co-prescription of 4 or more antihypertensive drugs. Data were obtained by matching of 2 French National Health Insurance Databases. SETTING: France. PARTICIPANTS: All affiliates, aged ≥75 years, receiving treatment for Alzheimer disease, alive on January 1, 2011 were included. MEASUREMENTS: We calculated the relative increase in the number of hospitalizations in patients with IAs. The analysis was performed over four 6-month periods. RESULTS: A total of 10,754 patients were included. During the periods with IAs, hospitalization rates increased by 0.36/year compared with 0.23/year in the periods without for the same patient, and the number of hospitalizations doubled [proportional fold change = 1.9, 95% confidence interval (1.8, 2.1)]. We estimated that 22% [95% confidence interval (20%, 23%)] of all hospitalizations were associated with IAs, 80% of which were due to psychotropic IAs. CONCLUSIONS: The IAs could be used as a simple and clinically relevant tool by prescribing physicians to assess the appropriateness of the prescription in elderly patients treated for Alzheimer disease.

来源:J Am Med Dir Assoc,查看原文。版权归原作者所有。

引用

  1. Zerah L, Boddaert J, Leperre-Desplanques A, et al. Association Between Psychotropic and Cardiovascular Iatrogenic Alerts and Risk of Hospitalizations in Elderly People Treated for Dementia: A Self-Controlled Case Series Study Based on the Matching of 2 French Health Insurance Databases. J Am Med Dir Assoc. 2017. PMID: 28330633. doi:10.1016/j.jamda.2017.02.001

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。